Our findings confirm most previous studies, that the tumor biology of IBC compared to SBC is worse in all factors studied: higher tumor stages, larger tumor sizes, higher gradings, higher Ki-67 levels, and higher proportions of negative hormone receptors, triple negative tumors, and HER-2 overexpression [14–16]. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.